Want to learn more?
Kantar's Post-DMARDs Market Dynamics Tracker for Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) delivers monthly market information that enables companies to make effective marketing decisions for the rapidly changing RA/AS/PsA market.
Faster information, one platform
Get up-to-date disease specific (RA/AS/PSA) Rx dynamics data. Get faster information compared to existing secondary data.
Detailed market information
Monitor patient potential and TX dynamics with smaller market segment - naive/switching post - DMARDS market (biologics/TT).
Establish counter strategies
Understand the correlation between market issues (intro of new agent, change of reimbursement guideline, etc.) and physician's Rx pattern change.